Zimmer Biomet Holdings, Inc. (ZBH) stock
ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3018% below fair value
$103.32+1.23 (+1.20%)
Close on Nov 18, 2026Market cap $19.71BP/E 25.1Yield 0.93%
Zimmer Biomet operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Zimmer Biomet's operating income for the twelve months ending Jun 30, 2026 was $1.21B, down 4.4% year over year. For fiscal 2025 it was $1.10B, down 14.6% from the year before. Over ten years it grew 8.9% a year on average. The highest annual figure on record is $1.29B in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.10B | -14.6% |
| FY2024 | Dec 31, 2024 | $1.29B | +0.6% |
| FY2023 | Dec 31, 2023 | $1.28B | +83.5% |
| FY2022 | Dec 31, 2022 | $696.30M | -19.1% |
| FY2021 | Dec 31, 2021 | $860.30M | +935.3% |
| FY2020 | Dec 31, 2020 | $83.10M | -92.7% |
| FY2019 | Dec 31, 2019 | $1.14B | +3265.4% |
| FY2018 | Dec 31, 2018 | $33.80M | -95.8% |
| FY2017 | Dec 31, 2017 | $799.30M | -2.7% |
| FY2016 | Dec 31, 2016 | $821.10M | +75.7% |
| FY2015 | Dec 31, 2015 | $467.30M | -55.0% |
| FY2014 | Dec 31, 2014 | $1.04B | -2.9% |
| FY2013 | Dec 31, 2013 | $1.07B | +2.0% |
| FY2012 | Dec 31, 2012 | $1.05B | +2.3% |
| FY2011 | Dec 31, 2011 | $1.02B | +11.7% |
| FY2010 | Dec 31, 2010 | $916.70M | -10.0% |
| FY2009 | Dec 31, 2009 | $1.02B | -6.5% |
| FY2008 | Dec 31, 2008 | $1.09B | -3.3% |
| FY2007 | Dec 31, 2007 | $1.13B | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $326.10M | +8.7% |
| Q1 FY2026 | Mar 31, 2026 | $373.20M | +27.7% |
| Q4 FY2025 | Dec 31, 2025 | $154.50M | -60.3% |
| Q3 FY2025 | Sep 30, 2025 | $351.30M | +25.7% |
| Q2 FY2025 | Jun 30, 2025 | $300.00M | -14.6% |
| Q1 FY2025 | Mar 31, 2025 | $292.30M | +9.9% |
| Q4 FY2024 | Dec 31, 2024 | $389.00M | +9.8% |
| Q3 FY2024 | Sep 30, 2024 | $279.50M | +4.8% |
| Q2 FY2024 | Jun 30, 2024 | $351.30M | +6.6% |
| Q1 FY2024 | Mar 31, 2024 | $265.90M | -18.8% |
| Q4 FY2023 | Dec 31, 2023 | $354.20M | – |
| Q3 FY2023 | Sep 30, 2023 | $266.60M | +8.7% |
| Q2 FY2023 | Jun 30, 2023 | $329.60M | +17.3% |
| Q1 FY2023 | Mar 31, 2023 | $327.30M | +65.0% |
| Q4 FY2022 | Dec 31, 2022 | -$28.30M | -121.2% |
| Q3 FY2022 | Sep 30, 2022 | $245.30M | +0.9% |
| Q2 FY2022 | Jun 30, 2022 | $280.90M | +25.0% |
| Q1 FY2022 | Mar 31, 2022 | $198.40M | -23.3% |
| Q4 FY2021 | Dec 31, 2021 | $133.80M | -67.5% |
| Q3 FY2021 | Sep 30, 2021 | $243.00M | -18.8% |
| Q2 FY2021 | Jun 30, 2021 | $224.80M | – |
| Q1 FY2021 | Mar 31, 2021 | $258.70M | – |
| Q4 FY2020 | Dec 31, 2020 | $411.60M | +22.2% |
| Q3 FY2020 | Sep 30, 2020 | $299.20M | +21.7% |
| Q2 FY2020 | Jun 30, 2020 | -$171.70M | -183.9% |
| Q1 FY2020 | Mar 31, 2020 | -$456.00M | -230.2% |
| Q4 FY2019 | Dec 31, 2019 | $336.80M | – |
| Q3 FY2019 | Sep 30, 2019 | $245.80M | +10.1% |
| Q2 FY2019 | Jun 30, 2019 | $204.70M | -30.8% |
| Q1 FY2019 | Mar 31, 2019 | $350.20M | +14.8% |
| Q4 FY2018 | Dec 31, 2018 | -$790.50M | – |
| Q3 FY2018 | Sep 30, 2018 | $223.30M | +5.7% |
| Q2 FY2018 | Jun 30, 2018 | $296.00M | +5.7% |
| Q1 FY2018 | Mar 31, 2018 | $305.00M | -12.4% |
| Q4 FY2017 | Dec 31, 2017 | -$40.10M | -122.5% |
| Q3 FY2017 | Sep 30, 2017 | $211.20M | +8.0% |
| Q2 FY2017 | Jun 30, 2017 | $280.10M | – |
| Q1 FY2017 | Mar 31, 2017 | $348.10M | – |
| Q4 FY2016 | Dec 31, 2016 | $178.50M | – |
| Q3 FY2016 | Sep 30, 2016 | $195.50M | – |
See a number that looks wrong?